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Abstract
Background: Anorexia of ageing (AA) may be considered as a risk factor for
frailty and has an important impact on quality of life, morbidity and mortality.
Methods: A systematic review and a meta-analysis were performed to sum-
marise the results from several trials on the effectiveness of treatments in
AA, as associated with depression, sensory impairment of taste and smell,
decreased appetite or early satiety, and disability. Eligible studies were
required to report baseline and follow-up values, the mean change (Δ-
change) from baseline, and/or the mean difference among intervention
groups versus control group, concerning food intake (kcal/daily) and/or
nutritional outcomes, such as body weight, body mass index, albumin and
Mini Nutritional Assessment.
Results: The systematic review included 20 papers based on different thera-
peutic approaches concerning food intake and/or nutritional outcomes. The
results of the meta-analysis indicate that the interventions for AA have an
important impact on body weight [+1.59 kg; 95% confidence interval
(CI) = 1.48–+1.71 kg; P < 0.001) and on energy intake (+56.09 kcal; 95%
CI = 54.05 to +166.25 kcal; P = 0.32). Regarding secondary outcomes, it
was not possible to meta-analyse the limited amount of data availab le.
Conclusions: The different variants of AA need to be defined because
diverse therapeutic approaches are available. A more precise definition of
the functional impairments associated with AA may allow a more correct
decision about the most appropriate therapy to be prescribed. Moreover,
this may allow for a more effective performance of the different therapeutic
approaches once they are better targeted to the different scenarios of AA.
Introduction
A reduction of appetite and food intake, namely, anorexia
of ageing (AA), is frequently observed in the elderly; it
can be considered as a risk factor for frailty, and it has a
relevant impact on quality of life, morbidity and mortal-
ity (1–6). Indeed, several studies conducted in community-
dwelling and institutionalised elderly subjects have
indicated that AA and unintentional weight loss are dom-
inant risk factors for protein-energy malnutrition, sar-
copenia, physical frailty and mortality, independent of
age, sex and other potential confounders (7,8). A number
of screening tools are available to identify subjects at risk
of developing anorexia, including Functional Assessment
of Anorexia/Cachexia Therapy; the Appetite, Hunger and
Sensory Perception Questionnaire; and the Simplified
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Nutritional Assessment Questionnaire (9–12). In clinical
practice, AA can be diagnosed when, in the absence of
alterations in the oral cavity that can affect the physiolog-
ical act of eating and/or masticatory function, sponta-
neous food intake is significantly reduced (≤50% of the
standard portion served or ≥25% of food left uneaten at
two-thirds of meals for ≥3 days) (13–15).
The prevalence of AA is highly variable in the different
epidemiological studies; it is approximately 30% in hospi-
talised subjects in acute care and rehabilitation wards and
it decreases in free-living subjects; however, it remains at
approximately 10% (7,16,17,18). Anorexia should not be
considered as an inevitable ‘side effect’ of ageing because
many risk factors, such as disability, depression, sensory
impairments, reduced chewing efficiency and a decline in
gastrointestinal functions, can be identified and poten-
tially corrected (19).
Macronutrient distribution can affect oral intake; a
higher proportion of energy from fat appears to increase
the satiety signal from glucagon-like peptide-1 and
decrease hunger (20). Protein intake moderately beyond
the recommended dietary allowances in older adults
appears to have a beneficial effect on muscle protein ana-
bolism and appetite regulation, favouring the preservation
of muscle mass at the same time as controlling body fat
(20). Different studies have confirmed the positive effects
of oral nutritional supplements in malnourished older
adults and different pharmaceutical approaches have been
used in AA (e.g. megesterol, meclobemide, tetrahydro-
cannabinol, cyproheptadine, cholecystokinin antagonists),
although the results are conflicting (21–25). Improving the
ambiance of dining rooms and assistance with meals (i.e.
allowing adequate time for caregivers to feed subjects
with disability or ‘slow-eaters’), encouraging the relatives
to be present during the mealtime and providing them
with ethnically appropriate food choices may be helpful
with respect to improving the nutritional status of free-
living elderly subjects and nursing home residents (26–28).
Therefore, a systematic review and a meta-analysis were
performed to summarise the findings from several tri-
als on the effectiveness of treatments in AA.
Materials and methods
The present systematic review was conducted in accor-
dance with the PRISMA (Preferred Reporting Items for
Systematic Review and Meta-Analyses) statement (29).
It was performed using the steps:
• Formulation of the review question: ‘anorexia of
ageing: treatment procedures’;
• Definition of participants: geriatric patients
(≥65 years), both sexes, from all settings;
• Search strategy for the identification of relevant inter-
vention studies on anorexia of ageing;
• Analysis of the data through the systematic review
and meta-analysis.
Search strategy
English-written articles were identified by searching the
Medline database (30), Scopus (31), ISI Web of Science (32)
and Google Scholar (33).
The search strategy was based on the search terms:
‘anorexia of aging’ AND ‘sensory impairment’ OR ‘taste
impairment’ OR ‘smell impairment’ OR ‘swallowing
impairment’ OR ‘chewing impairment’ OR ‘depression’ OR
‘feeding’ OR ‘oral supplement’ OR ‘enriched meal’ OR’ ex-
ercise’ OR ‘nutritional intervention’. In a first stage, four
individuals (SP, MR, LMD and EP) independently per-
formed a systematic review of the literature, employing
the same search strategy. In a second stage, duplicate
records were removed and discrepant records were care-
fully investigated within these four individuals before
selecting retrieved papers for full-text review.
Eligible studies were required to report baseline and fol-
low-up values, the mean change (Δ-change) from baseline,
and/or the mean difference among intervention groups
versus control group, concerning food intake (kcal day–1)
and/or nutritional outcomes [such as body weight (BW),
body mass index (BMI), plasma albumin levels, Mini
Nutritional Assessment (MNA) score]. Studies in subjects
with any cancers in the terminal phase, with good nutri-
tional status (MNA > 23.5), with any acute diseases,
uncertain life expectancy or undergoing artificial nutri-
tion, palliative care or chemotherapy, were excluded.
Analysis of the data and presentation of the outcomes
Clinical trials investigating the effectiveness of dietary or
pharmacological treatment in AA were included. For each
study, the data specified were: the author, the name of
the journal in which the study was published and the year
of publication, the number and age of participants
enrolled in the study, the drop-out rate, the study charac-
teristics, and the therapeutic intervention, duration and
outcomes. A meta-analysis for pooled estimate for aggre-
gated data was performed.
Risk of bias in individual studies
The risk of bias of each study was assessed using the
Cochrane Collaboration Risk of Bias tool (34) and, consid-
ering as factors contributing to the study quality, the
generation of the allocation sequence, allocation conceal-
ment, blinding of outcome data, the presence of incom-
plete data and selective reporting. These factors were
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classified as low risk of bias, high risk of bias or an
unclear risk of bias. Studies with a low risk of bias for at
least three items were considered as good; studies with a
low risk of bias for at least two items were considered as
fair, and studies with a low risk for no item or only for
one item were regarded as poor. Only randomised con-
trolled trials were included in the meta-analysis.
Results
The literature search retrieved 322 papers via database
searching and 84 papers were selected via full-text revision.
Sixty-four studies were excluded. The 20 remaining studies
(17 clinical trials, all presenting a control group and three
observational studies) were selected for the present system-
atic review. The systematic review includes 20 studies with
a total of 1515 adults aged 59–99 years. Of these 20, 12
randomised clinical trials were included in a meta-analysis.
Figure 1 shows the study selection procedure.
The general data concerning the different studies are
provided in the Supporting information (Table S1), as
are the specific interventions and the results obtained (see
Supporting information, Table S2). The duration of the
studies was from 8 weeks to 24 months.
The inclusion criteria considered in the selected studies
are very different, with a diverse combination of parame-
ters: accidental weight loss, low BMI (<18, 21 or
25 kg m–2 in different studies), BW below 80% of ideal
weight, reduced levels of albumin (<35 or 38 g L–1 in dif-
ferent studies), prealbumin serum levels < 0.18 g L–1,
MNA score below 23.5, the concurrence of acute illness
or the presence of chronic illness or dementia, and the
need for assistance during meals.
The definition of AA in the different studies was based
on:
• Reduced dietary intake [not specifically quantified in
six studies; objectively quantified (left more than 25% of
their food uneaten at two-thirds of meals) in two studies;
evaluating reduced dietary intake and sensory perceptions
(olfactory sensitivity; appetite, hunger, sensory percep-
tion) in one study];
Records idenfied through 
database searching
(n = 435)
Addional records idenfied 
through other sources
(n = 432)
Records aer duplicates removed(n = 322 )
Arcles retrieved for full-
text review (n = 84)
Full-text arcles excluded, 
with reasons
(n = 64)
Studies included in 
qualitave synthesis
(systemac review)
(n = 20)
Studies included in 
quantave synthesis 
(meta-analysis)
(n = 12)
Arcles excluded aer reading the 
abstract (n = 238)
23 included subjects with 
acute diseases
14 used arficial nutrion
18 included subjects
undergoing chemotherapy
9 included subjects that were 
not matching AA definion
Figure 1 Flow diagram of the study.
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• Self-reported poor or fair appetite in one study;
• MNA score (considering the item aimed at assessing
appetite in one study or the global score referring to the
definition of ‘at risk of malnutrition’ in four studies);
• The presence of malnutrition (one study) or risk of
undernutrition according to the physician judgment (two
studies);
• The presence of disability that can affect eating in
three studies.
The types of intervention were classified into five
groups: pharmacological approaches (13,35,36), nutritional
interventions or supplementation (37–46), flavour enhance-
ment (47–49), assistance with meals (50–52), combination of
nutritional intervention and exercise programme (53).
Results of interventions
Considering the different interventions
• Pharmacological approaches: antidepressants were
effective with respect to increasing BW, MNA score and
serum albumin levels significantly (P < 0.05) in subjects
without dementia (35), whereas, in the study conducted
by Wilson et al. (13) (using dronabinol), weight gain was
not significant. Megestrol acetate was used in one ran-
domised controlled trial conducted in 47 elderly subjects,
recently discharged from an acute care hospital, with fair
or poor appetite. Participants were randomised to four
different intervention groups (placebo or megestrol acet-
ate 200, 400 mg or 800 mg day–1) for 9 weeks. No signif-
icant differences were found between treatment groups
with respect to appetite and albumin levels, whereas pre-
albumin increased in a dose–response relationship (36).
• Nutritional intervention or supplementation: hot eve-
ning meal, protein and energy enriched soups and sauces
or supplementation [with cookies or oral nutritional sup-
plements (ONS)] were effective with respect to improving
significantly (P < 0.05) nutritional parameters (energy
intake, BW, BMI, albumin concentrations, MNA score)
(37,39–43,45). ONS were not effective only in the study con-
ducted by Bos et al. (44), whereas a hot evening meal was
not effective in the study conducted by Odlund et al. (38);
• Flavour enhancement: flavour enhancers and sauces
added to the main dish were effective with respect to sig-
nificantly increasing BW or energy intake in two studies
(47,49), whereas they did not improve any nutritional
parameters in the study by Essed et al. (48);
• Meal assistance: assistance with the meal was effective
with respect to significantly increasing different nutri-
tional parameters especially energy intake and MNA score
(P < 0.05), whereas it did not affect BW or BMI (50–52);
• Combination of nutritional intervention and exercise: in
the only study adopting this approach, this was not found
to be effective with respect to improving BW, BMI,
energy intake or albumin concentrations (53).
Considering the different nutritional outcomes:
• Changes in body weight: seven clinical trials
(35,37,39,40,45–47) using different approaches, including
antidepressants, hot evening meal, protein and energy
enriched soups and sauces supplementation with cookies,
flavour enhancers and ONS, demonstrated a statistically
significant increase in intervention groups. BW varied
from +0.73 to +2.4 kg depending on the study
(P < 0.05). Five other trials using different approaches,
such as assistance with the meal, flavour enhancers and
other nutritional interventions or supplementation, found
no significant weight gain (44) or registered a nonstatisti-
cally significant weight gain in the intervention groups
compared to the control groups (38,42,43,50). Finally, two
observational studies reported contradictory observations:
in the study conducted by Wilson et al. (13) (using dron-
abinol), the increase in BW was not significant, whereas,
in the study by Cruz-Jentoft et al. (43), the use of ONS
led to a significant increase in BW (+2.1 kg; P < 0.0001);•
Changes in body mass index: in three randomised clini-
cal trials based on nutritional interventions or supple-
mentation (39,40,45), BMI increased significantly in
intervention groups (BMI: +0.5, +0.8 and +1.3 kg/m2,
respectively; P < 0.05) compared to the control group,
whereas the change in BMI was not significant in other
studies using hot evening meals, feeding assistance or
ONS (38,43,51);
• Changes in albumin levels (in g L–1 and/or as a per-
centage): the three studies that evaluated the effects of
interventions in terms of albumin levels produced con-
trasting results: both significant and nonsignificant
increases or decreases. In a longitudinal study using
antidepressants (35) albumin levels increased significantly
(+1.78 g L–1; P < 0.05) in subjects without dementia,
whereas the increase in subjects with dementia was not
statistically significant. In another study using ONS (39), a
statistically significant decrease in albumin levels was
observed in both intervention and control groups (2.0
and 2.6%, respectively; P < 0.05). In a randomised clin-
ical trial performed by Wouters-Wessling et al. (40) (using
ONS), a nonsignificant increase in albumin levels was
found in both intervention (+1.3 g L–1) and control
groups (+1.4 g L–1);
• Changes in Mini Nutritional Assessment score: three
randomised controlled trials (42,45,50) and one observa-
tional study (43) using nutritional intervention/supple-
mentation and assistance with meal showed a significant
increase in MNA score in intervention groups (+3.6, +3,
+1 and +2.5 points, respectively; P < 0.05).The results of
the study conducted by Thomas et al. (35) (based on
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antidepressant therapy) showed a significant increase in
MNA score (+0.76 points; P < 0.05) in subjects without
dementia, whereas, in subjects with dementia, the increase
was not significant;
• Changes in energy intake: four studies (41,49,50,52) (us-
ing different approaches: dronabinol, nutritional interven-
tion or supplementation, assistance with a meal) showed
a statistically significant increase in energy intake in inter-
vention groups (energy intake variation: from +115 to
+341 kcal day; P < 0.05). By contrast, two studies (48,53)
(using assistance with a meal and a combination of nutri-
tional intervention and exercise programme, respectively),
found no significant variation in energy intake in the
intervention groups.
Meta-analysed data
The meta-analysed mean differences for random effects
(MD) showed a significantly greater increase in BW
(MD = 1.59 kg; range = 1.47 to 1.71; P < 0.01) (Fig. 2)
and in energy intake (MD = 56.09 kcal; range = 54.05
to 166.24; P = 0.32) regardless of the approach adopted
to treat AA (Fig. 3).
In the five studies (40,42,47,48,50) (242 subjects in the
intervention groups and 232 subjects in the control
groups) that considered BW as an outcome variable,
there was a significant increase (Fig. 2) when comparing
the results of the intervention groups with those of the
control groups. The test for heterogeneity indicated that
the treatment effect was not significantly different
between the considered studies (P < 0.93) with I2 val-
ues = 0%. Mean differences of random effects showed a
change in BW of 0.8 (7.68, +6.08) kg, 0.0 (6.8,
+6.8) kg, 0.90 (7.75, +5.95) kg (48), +1.51 (+0.09,
+2.93) kg (42), +1.40 (+0.69, +2.11) kg (47), +1.60 (+1.48,
+1.72) kg (50), +2.2 (+0.41, +3.99) kg (40) between groups,
as shown in Fig. 2 as mean difference IV random effects.
In four studies (41,48,50,53) considering the energy intake
as the outcome variable (634 subjects in the intervention
groups and 265 subjects in the control groups), there was
no significant increase in energy intake (Fig. 3) when
comparing the results of the intervention groups to the
control groups. However, the tests for heterogeneity indi-
cated that the treatment effect was significantly different
between the different studies (P < 0.001) with I2 = 96%.
Mean differences of random effects between groups
showed changes in energy intake of +36 (67, +139) (41),
0 (171, +171), +141 (52, +335), +119 (75, +314)
(53), 20 (85, +45), 16 (70, +37), 5 (61, +51)
(48) and +215 (+202, +228) (50) kcal, as shown in Fig. 3 as
mean difference IV random effects.
Risk of bias
Figure 4 shows the methodological quality of the studies.
Only nine studies were suitable for all the five items
considered for the methodological quality assessment
(six studies were blinded for the variables considered).
In summary, no studies were rated as appropriate in
random sequence generation and in allocation conceal-
ment, 75% of the studies were rated as appropriate in
blinding of participants and personnel, 75% of the stud-
ies were adequate in blinding of the outcome assess-
ment, 80% reported incomplete outcome data, 90%
gave only a selective reporting, and 75% showed other
bias.
Study or Subgroup
Essed 2007
Essed 2007
Essed 2007
Gazzotti 2003
Lauque 2000
Lundholm 2004
Mathey 2001
Nijs 2006
Pouyssegur 2015
Smoliner 2008
wouters-welling 2002
Total (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 1.94, df = 6 (P = 0.93); I² = 0%
Test for overall effect: Z = 27.08 (P < 0.00001)
Mean
–0.8
–0.7
0.1
0.28
1.47
1.5
1.1
0.5
2.01
2
1.4
SD
3.3
3.6
2.4
3.8
0
0
1.3
0.4
0
0
2.4
Total
20
20
17
39
37
137
36
94
88
22
16
242
Mean
0.1
0.1
0.1
–1.23
–0.93
0
–0.3
–1.1
–0.46
1.6
–0.8
SD
14.9
14.9
14.9
2.5
0
6.6
1.6
0.4
0
0
3
Total
19
19
19
41
41
169
31
84
87
30
19
232
Weight
0.0%
0.0%
0.0%
0.7%
2.7%
96.2%
0.4%
100.0%
IV, Random, 95% CI
–0.90 [–7.75, 5.95]
–0.80 [–7.68, 6.08]
0.00 [–6.80, 6.80]
1.51 [0.09, 2.93]
Not estimable
Not estimable
1.40 [0.69, 2.11]
1.60 [1.48, 1.72]
Not estimable
Not estimable
2.20 [0.41, 3.99]
1.59 [1.48, 1.71]
Intervention Control Mean difference
Risk of bias legend
(A) Random sequence generation (selection bias)
(B) Allocation concealment (selection bias)
(C) Blinding of participants and personnel (performance bias)
(D) Blinding of outcome assessment (detection bias)
(E) Incomplete outcome data (attrition bias)
(F) Selective reporting (reporting bias)
(G) Other bias
+ + – + – – +
+ + – + – – +
+ + – + – – +
+ + + – + + +
+ + – + + + –
+ + + + + + –
+ + + + – + –
+ + + – + + +
+ + + + + + +
+ + + + + + +
+ + + + + + +
Risk of bias
A B C D E F G
Mean difference
IV, Random, 95% CI
–100 –50 0 50 100
Favours [experimental] Favours [control]
Figure 2 Effectiveness of treatments on body weight in the randomised controlled clinical trials included in the meta-analysis. CI, confidence
interval.
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Discussion
This systematic review was able to select only a limited
number of papers based on different therapeutic
approaches, yielding contrasting results. The recent sys-
tematic review conducted by Malafarina et al. (54) con-
cluded that these treatments were not effective for AA
because they were not able to modify significantly the
concentration of peptides involved in appetite control.
The results of this meta-analysis indicate that the inter-
ventions for AA have an important impact on BW
(+1.59 kg, P < 0.001), whereas the effects on energy
intake (+56.09 kcal, P = 0.32) do not appear to be statis-
tically significant. With regard to secondary outcomes,
such as albumin levels, MNA score and BMI changes, it
was not possible to meta-analyse the data as a result of
the limited amount of data available.
Although numerous studies suggest different
approaches for managing AA, evidence based on ran-
domised controlled clinical trials is scarce. It is important
to note that following a nutritional support could be dif-
ficult for this population as a result of the coexistence of
many factors: loss of appetite, inactivity, sensory impair-
ment, early satiation, psychological disorders and mental
impairments. Furthermore, AA treatment requires a mul-
tidimensional approach, including food manipulation
(improvement of flavour, food texture and palatability,
increasing dietary variety, and feeding assistance), correc-
tion of environmental threat (preventing social isolation
and improving conviviality, particularly in nursing home
residents, providing adequate individual feeding assis-
tance, changing the mealtime routine, modifying the din-
ing environment, and staff training), reduction of
pharmacological risk factors (a certain number of cardio-
vascular, psychiatric and anti-rheumatic drugs may
reduce appetite) and treatment of underlying medical
causes (swallowing disorders, dyspepsia, malabsorption
syndromes, neurological causes, endocrine and psychiatric
disorders, respiratory diseases and cardiovascular dis-
eases), as recommended in mumerous studies (26,55–59).
Study or Subgroup
Chu 2001
De Jong 1999
De Jong 1999
De Jong 1999
Essed 2007
Essed 2007
Essed 2007
Nijs 2006
Total (95% CI)
Heterogeneity: Tau² = 21747.34; Chi² = 172.26, df = 7 (P < 0.00001); I² = 96%
Test for overall effect: Z = 1.00 (P = 0.32)
Mean
301
–95.54
45.77
23.88
7.64
4.06
18.63
115
SD
95
334.34
286.62
310.5
67.5
106.29
84.07
47
Total
9
397
35
39
19
19
22
94
634
Mean
265
–95.54
–95.54
–95.54
24
24
24
–100
SD
133
501.58
501.58
501.58
107
107
107
39
Total
10
34
34
34
23
23
23
84
265
Weight
12.9%
10.7%
10.0%
10.0%
14.0%
13.8%
14.0%
14.5%
100.0%
IV, Random, 95% CI
36.0000 [–67.1857, 139.1857]
0.0000 [–171.7744, 171.7744]
141.3100 [–52.1878, 334.8078]
119.4200 [–75.3135, 314.1535]
–16.3600 [–69.5897, 36.8697]
–19.9400 [–84.7194, 44.8394]
–5.3700 [–61.4621, 50.7221]
215.0000 [202.3575, 227.6425]
56.0966 [–54.0536, 166.2469]
Intervention Control Mean difference
Risk of bias legend
(A) Random sequence generation (selection bias)
(B) Allocation concealment (selection bias)
(C) Blinding of participants and personnel (performance bias)
(D) Blinding of outcome assessment (detection bias)
(E) Incomplete outcome data (attrition bias)
(F) Selective reporting (reporting bias)
(G) Other bias
+ + + + + + +
+ + + – + + +
+ + + – + + +
+ + + – + + +
+ + – + – – +
+ + – + – – +
+ + – + – – +
+ + + – + + +
Risk of bias
A B C D E F G
Mean difference
IV, Random, 95% CI
–100 –50 0 50 100
Favours [experimental] Favours [control]
Figure 3 Effectiveness of treatments on energy intake in the randomised controlled clinical trials included in the meta-analysis. CI, confidence
interval.
Random sequence generation (selection bias)
Allocation concealment (selection bias)
Blinding of participants and personnel (performance bias)
Blinding of outcome assessment (detection bias)
Incomplete outcome data (attrition bias)
Selective reporting (reporting bias)
Other bias
0% 25% 50% 75% 100%
Low risk of bias Unclear risk of bias High risk of bias
Figure 4 Summary of bias in either outcome considered: body weight and energy intake.
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Special attention should be also given to the nutritional
screening tools, which constitute the primary intervention
in the treatment of AA. MNA-Short Form and MNA-
Long Form are considered among the best screening
questionnaires, with a high accuracy for the prediction of
malnourished elderly subjects, although the most recent
versions of Nutritional Risk Screening also show good
results in terms of compliance of subsequent nutritional
treatments in younger residents of multiple healthcare
sites, and perhaps this result could be significant also for
older adults (60,61). Additionally, the use of body composi-
tion and functional assessment techniques has become
more frequent in the evaluation of nutritional status, with
an improvement of the health outcomes of subjects,
although clinical practice should evolve even more in this
area, moving beyond current approaches (62).
Pharmacological approaches to AA have focused on
research trials, in particular on interventions that try to
modify neuropeptide regulation (administration of ghre-
lin, cholecystokinin and Melanocortin 4 receptor antago-
nists, drugs blocking protein catabolism) (51). Thomas
et al. (35) examined the effects of antidepressant therapy
(mainly serotonin reuptake inhibitors; SSRIs) in AA asso-
ciated with depression. Antidepressants were effective
with respect to increasing BW, MNA score and albumin
concentrations both in subjects with or without dementia.
Previously, a study by Hilas et al. (57) involving mirtazap-
ine assessed its favourable effects on appetite and weight
in adults compared to placebo and other antidepressants.
Mirtazapine may have multiple effects in subjects
with weight loss because it relieves symptoms associated
with depression, it regulates the gastrointestinal motor or
sensory functions, and it significantly increases BW
(mainly as a result of growth of visceral fat) (63). Another
study (64), comparing the effects of older tricyclic antide-
pressants (TCAs) and newer SSRIs in relation to weight
gain in nursing home residents showed that TCAs do not
contribute to weight gain more than other antidepres-
sants.
In studies that considered subjects with AA combined
with decreased appetite (13,37–43) or with early satiety
(44,45,53), interventions focused on nutritional interven-
tions characterised by providing an additional intake of
cookies with high protein/energy density, liquid oral sup-
plements enriched with micronutrients, a hot evening
meal or adding flavour enhancers to the main dish. The
results obtained in most of these studies, where decreased
appetite was involved, showed an increase in BW and
energy intake, whereas ONS combined with an exercise
programme was not effective in the studies where AA was
combined with early satiety (65,66). A recent systematic
review of the literature suggests that increasing energy/nu-
trients density of food intake may increase energy intake
in older adults with anorexia (67). It should be empha-
sised, as suggested by Yeomans et al. (68), that ONS pre-
loads (mainly maltodextrin) may reduce the general
desire to eat, whereas the administration of dietary sup-
plements between meals is more effective with respect to
increasing energy consumption (69).
Sensory impairments in the elderly can lead to a
reduced enjoyment of food and then to AA and, by this
route, to a greater risk of frailty in community-dwelling
elderly people (70). A reduced ability to differentiate
between various intensities or concentrations of taste and
smell can result in anorexia (71). With respect to the treat-
ment of AA combined with sensory impairment of taste
and smell, flavour enhancers or sauces added to the main
dish were effective with respect to increasing BW or
energy intakes in two studies (47,49), whereas they did not
elicit any improvements in nutritional parameters in the
study by Essed et al. (48). In the literature, considering
different groups of subjects, the results remain contradic-
tory: a study conducted by Havermans et al. (72) found
that flavour intensification did not alter sensory-specific
satiety, whereas other studies suggest that the consump-
tion of food with enhanced chemosensory properties
could provide nutritional benefits and help to prevent
weight loss. In particular, monosodium glutamate (MSG)
appears to be effective with respect to improving both
flavour enhancement and food intake (73). However, in
the study conducted by Essed et al. (48) MSG (0.5% and
2%) did not appear to be effective with respect to
improving food intake in an elderly sample. In addition,
a recent systematic review considering studies conducted
in all age groups could not provide sufficient evidence to
recommend zinc supplementation for improving taste
perception or acuity in zinc deficiency-related or idio-
pathic dysgeusia (74,75).
The treatment of AA associated with disability is
mainly characterised in the selected studies by assistance
with meals and repeated measurement of BW (46,50–52).
In this category of subjects, the administration of fruits
and high protein supplements, as suggested by Lauque
et al. (46), appears to be effective. Moreover, an exercise
programme may affect the regulation of energy balance
through the stimulation of corticotrophin-releasing hor-
mone (CRH) and neuropeptide Y (NPY). In particular,
NPY, by producing orexigenic effects and reducing ther-
mogenesis, tends to counterbalance the physiological
effects of CRH and therefore overcomes the effects of
exercise on energy loss (76). Unfortunately, the only
study considered in this systematic review using an
exercise programme (focused on skill training, including
strength, endurance, coordination and flexibility) (53)
did not show beneficial effects: energy intake, BW and
BMI were not positively affected by the intervention
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combining nutrient-dense products and an exercise
programme.
Strength and limitations of the present study
The strength of this systematic review is represented by
an attempt to analyse the practical interventions proposed
for AA when considering diverse clinical scenarios based
on its combination with different functional impairments.
Indeed, AA combined with disability, for example, may
be very different in clinical manifestations compared to
AA combined with sensory impairment, depression or
lack of appetite/early satiation. A limitation of the present
study is therefore represented by the limited number of
studies that were selected, or even available and appropri-
ate for inclusion, especially for the meta-analysis that
could consider only BW and energy intake as study out-
come variables.
Conclusions
It is necessary to define the different variants of AA
because diverse therapeutic approaches are available. A
better definition of the functional impairments combined
with AA may allow a more correct decision to be made
about the most appropriate combination of therapies to
be prescribed. Moreover, this may allow for a greater effi-
cacy of the different therapeutic approaches once they are
better targeted to the different clinical scenarios of AA.
Finally, different treatments show a potentially favourable
effect on BW (or BMI), energy intake, albumin levels and
MNA score, suggesting the need for further research
using long-term intervention studies in large study groups
in with the aim of defining the best approach for the
management of AA.
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